Literature DB >> 6167050

An approach to the management of neovascularization of the iris and secondary glaucoma.

S J Ryan.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 6167050      PMCID: PMC1312133     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  27 in total

1.  Retinal vascularization in health and disease: Proctor Award Lecture of the Association for Research in Ophthalmology.

Authors:  N ASHTON
Journal:  Am J Ophthalmol       Date:  1957-10       Impact factor: 5.258

Review 2.  Neovascularization of the iris (rubeosis iridis).

Authors:  S Gartner; P Henkind
Journal:  Surv Ophthalmol       Date:  1978 Mar-Apr       Impact factor: 6.048

3.  Goniophotocoagulation for neovascular glaucoma.

Authors:  R J Simmons; D K Dueker; R L Kimbrough; L M Aiello
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1977 Jan-Feb

4.  Iris fluorescein angiography in diabetic vitrectomy patients.

Authors:  Z N Zakov; M L Lewis
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-04-07

5.  Implants for draining neovascular glaucoma.

Authors:  A C Molteno; M M Van Rooyen; R S Bartholomew
Journal:  Br J Ophthalmol       Date:  1977-02       Impact factor: 4.638

6.  Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma.

Authors:  M Wand; D K Dueker; L M Aiello; W M Grant
Journal:  Am J Ophthalmol       Date:  1978-09       Impact factor: 5.258

7.  Surgical complications of pars plana vitreous surgery.

Authors:  J Faulborn; B P Conway; R Machemer
Journal:  Ophthalmology       Date:  1978-02       Impact factor: 12.079

8.  Preoperative iris rubeosis and diabetic vitrectomy results.

Authors:  G Blankenship
Journal:  Ophthalmology       Date:  1980-03       Impact factor: 12.079

9.  Role of cell shape in growth control.

Authors:  J Folkman; A Moscona
Journal:  Nature       Date:  1978-06-01       Impact factor: 49.962

10.  Rubeosis iridis.

Authors:  R R Schulze
Journal:  Am J Ophthalmol       Date:  1967-03       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.